Diabetic Cardiomyopathy
- PMID: 30973809
- PMCID: PMC6578576
- DOI: 10.1161/CIRCRESAHA.118.314665
Diabetic Cardiomyopathy
Abstract
Diabetic cardiomyopathy was initially described as a human pathophysiological condition in which heart failure occurred in the absence of coronary artery disease, hypertension, and valvular heart disease. Recent studies in diabetic animal models identify decreased cardiomyocyte function as an important mediating mechanism for heart failure. Decreased cardiomyocyte function is in part mediated by abnormal mitochondrial calcium handling and a decreased level of free matrix calcium levels which could be a good target for new therapeutic interventions.
Keywords: calcium; coronary artery disease; diabetes mellitus; diabetic cardiomyopathy; heart failure; mitochondria.
References
-
- Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Amer J of Cardiology 1972;30:595. - PubMed
-
- Kannel WB, Hjortland M, Castelli WP Role of diabetes in congestive heart failure; the Framingham study, Am J Cardiol 1974;34:29–34. - PubMed
-
- Penpargkul S, Fein F, Sonnenblick EH, Scheuer J. Depressed cardiac sarcoplasmic reticular function from diabetic rats. J Mol Cell Cardiol 1981;13:303–9. - PubMed
-
- Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 2002;51:1166–71. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
